tiprankstipranks
Trending News
More News >
Colony Bankcorp (CBAN)
NYSE:CBAN
US Market

Colony Bankcorp (CBAN) AI Stock Analysis

Compare
125 Followers

Top Page

CBAN

Colony Bankcorp

(NYSE:CBAN)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
$20.50
â–²(20.59% Upside)
Action:DowngradedDate:03/14/26
The score is driven primarily by solid financial performance (strong revenue and profitability, improving capital) but held back by weak and volatile cash flow and a softening return profile. Earnings-call guidance supports improvement in profitability and margins, while technical indicators remain weak in the near term. Valuation is a relative positive with a low P/E and a moderate dividend yield.
Positive Factors
Merger with TC Bancshares
The merger with TC Bancshares significantly enhances Colony Bankcorp's market position and service capabilities in key Southeast markets, potentially driving long-term growth and competitive advantage.
Net Interest Margin Expansion
The expansion in net interest margin reflects effective pricing strategies and loan growth, contributing to improved profitability and financial stability over the long term.
Strong Free Cash Flow Growth
Robust free cash flow growth indicates strong cash generation capabilities, enhancing financial flexibility and supporting future investments and debt management.
Negative Factors
Rising Operating Expenses
Increased operating expenses due to investments in talent and growth initiatives could pressure margins and reduce profitability if not offset by revenue growth.
Higher Charge-offs in SBA Division
Higher charge-offs in the SBA division may indicate credit quality issues, potentially impacting future earnings and necessitating more conservative lending practices.
Slowdown in Mortgage and SBSL Divisions
A slowdown in mortgage and SBSL divisions due to changes in SBA lending guidelines and a slower housing market could limit revenue growth in these segments.

Colony Bankcorp (CBAN) vs. SPDR S&P 500 ETF (SPY)

Colony Bankcorp Business Overview & Revenue Model

Company DescriptionColony Bankcorp (CBAN) is a publicly traded bank holding company based in Georgia, primarily engaged in providing a range of banking and financial services through its subsidiary, Colony Bank. The company operates in the financial services sector and offers products such as personal and commercial banking, mortgage loans, and treasury management services. Colony Bank caters to individuals, small to medium-sized businesses, and various organizations, focusing on community-oriented banking solutions.
How the Company Makes MoneyColony Bankcorp primarily makes money through its banking operations. The largest driver is generally net interest income: it earns interest and fees on interest-earning assets (especially commercial and consumer loans and, to a lesser extent, investment securities) and pays interest on funding sources (primarily customer deposits and, if used, wholesale borrowings); the spread between these yields and costs is a key contributor to earnings. A second contributor is noninterest income generated from fees and service charges associated with deposit accounts (e.g., account maintenance and transaction-related fees) and other banking services provided to customers; specific categories beyond deposit-related fees are null. Offsetting these revenues are major cost and risk factors, including provisions for credit losses on loans, operating expenses (personnel, occupancy, technology, and other administrative costs), and the impact of interest-rate changes on both loan yields and deposit/borrrowing costs. Significant partnerships specifically contributing to earnings are null.

Colony Bankcorp Earnings Call Summary

Earnings Call Date:Jan 28, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Positive
The call presented a largely constructive picture: management achieved key profitability targets (1.0% operating ROA for 2025), reported quarter-over-quarter margin and net interest income improvement, successful close of the TC Federal acquisition with better-than-expected deal economics, and meaningful growth in complementary businesses (AUM doubling, insurance referrals +20%). Near-term lowlights include elevated operating expenses and merger-related costs until the systems conversion is complete, elevated provisions/charge-offs concentrated in specific higher-risk product lines, and an increase in criticized/classified and nonperforming loans driven in part by the acquisition. Management expects most merger-related cost savings and expense improvements to materialize in Q2 2026 and is guiding to modest margin expansion and slightly lower organic loan growth (~8%) in 2026. Overall, the positives—successful acquisition execution, margin expansion, strong FY loan growth, and improvements in complementary businesses—outweigh the near-term integration and credit noise, with a path to realizing cost saves and continued profitability improvement.
Q4-2025 Updates
Positive Updates
Successful TC Federal Acquisition and Integration Progress
Legal close completed at beginning of December; systems conversion on track for Q1 2026. Management reports deal financial targets are on track or better than expected and projected cost savings and deal economics improved versus original modeling (earn-back now expected to be <2.5 years).
Improved Operating Performance and Profitability
Operating net income increased by $675,000 quarter-over-quarter. Achieved a 1.0% operating ROA for fiscal year 2025 (management target) and set a new target of 1.20% ROA with expectation to achieve quarterly beginning Q2 2026 and full-year 2026.
Net Interest Income and Margin Expansion
Net interest income rose approximately $3.2 million versus the prior quarter. Net interest margin increased 15 basis points to 3.32% in the quarter, driven by higher earning asset yields and lower cost of funds.
Strong Loan Yield and Core Loan Growth
Loan yields increased to 6.19% from 6.15% quarter-over-quarter. Core organic loan growth for 2025 was 10.5% (excluding the TC Federal acquisition). Management expects modest margin expansion through 2026 driven by loan repricing.
Robust Complementary Lines of Business and Noninterest Income
Operating noninterest income was $11.1 million in Q4 with notable strength in mortgage and SBSL. Executed a $10 million portfolio mortgage pool sale with a gain of about $108,000. Management expects noninterest income to be slightly better in 2026.
Asset Management and Insurance Growth
Assets under management more than doubled from ~ $200 million at end of 2024 to over $460 million at end of 2025. Bank referrals to insurance increased 20% in 2025 and Colony Insurance showed year-over-year improvement in items and premiums in force.
Capital, Book Value and Shareholder Returns
Tangible common equity (TCE) ratio improved to 8.30% (from 8.00% prior quarter). Tangible book value per share increased to $14.31 from $14.24. Board increased quarterly dividend to $0.12 per share (up $0.02 annualized) and repurchased 47,000 shares at an average price of $16.50.
Balance Sheet and AOCI Improvements
Fair value of the investment portfolio improved quarter-over-quarter, producing a positive impact to accumulated other comprehensive income (AOCI) of about $2.5 million. Management highlighted opportunity to re-deploy payoffs at current market rates to support earnings.
Recognition and Talent Additions
Colony named one of American Bankers 2025 Best Banks to Work For (only Georgia-headquartered bank on the list). Added two financial advisers and transitioned to a dual-employee broker-dealer model; expects long-term revenue upside from AUM and adviser model conversion.
Negative Updates
Elevated Operating Expenses and Near-Term Merger Costs
Operating noninterest expenses were $24.4 million in Q4 and net noninterest expense to average assets was 1.58%, above historical averages. Management is carrying TC Federal-related expenses until systems conversion; merger-related expenses were cited at approximately $1.3 million for the quarter and a majority of cost saves are expected after conversion (targeting ~1.45% by Q2 2026).
Higher Provision and Charge-Off Activity
Provision expense increased to $1.65 million in Q4 (from $900,000 prior quarter). Net charge-offs were $1.6 million, slightly down from prior quarter but still elevated versus earlier periods; charge-offs were primarily from the SBSL division and third-party marketplace loans.
Asset Quality Impact from Acquisition and Nonperforming Loans Increase
Classified and criticized loans increased quarter-over-quarter with a large portion attributable to TC Federal (68% of the criticized increase and 93% of the classified increase). Nonperforming loans increased by $9 million quarter-over-quarter, with $6 million due to the TC Federal acquisition (acquisition accounting captured anticipated losses).
Organic Loan Growth Weakness in Q4 and Guidance Moderation
Organic loan growth was flat in the quarter (driven by payoffs) and management now expects 2026 organic loan growth to be nearer the lower end of the 8%–12% target (around 8%) due to increased competition and pricing pressure.
Margin Pressures from Competitive Pricing and Rate Environment
Weighted average rate on new and renewed loans was 7.33% (down from the prior quarter) and is expected to fall closer to prime. Management noted increased competition in lending and some pressure to be more price-competitive to achieve growth.
Deposit Mix and Pricing Effects
Deposits were up for the quarter but organically flat year-over-year (excluding TC Federal). Management has aggressively lowered rates on interest-bearing accounts during recent rate cuts, resulting in loss of some non-relationship, price-sensitive accounts; deposit growth needs continued focus to fund loan growth organically.
Concentration and Marketplace Loan Risk
SBSL and marketplace loans (together ~5% of total loan portfolio) generated higher yields but also accounted for a meaningful portion of charge-offs in Q4. Management expects some improvement going forward but acknowledged variability in those lines.
Company Guidance
The company guided to steady improvement in 2026, targeting a 1.20% operating ROA on a quarterly basis beginning in Q2 2026 (and 1.20% for full-year 2026) after achieving a 1.00% operating ROA for fiscal 2025; core loan growth was 10.5% in 2025 (ex‑TC Federal) and 2026 organic loan growth is expected nearer the low end of the 8%–12% target (around 8%); net interest margin, which rose 15 bps to 3.32% in Q4 (net interest income +$3.2M QoQ, loan yield 6.19% vs. 6.15%), is projected to increase modestly (mid‑single digits each quarter) as cost of funds continues to fall (1.96% in Q4, down from 2.03% in Q3); operating noninterest income was $11.1M in Q4 and is expected to be slightly better in 2026, helped by mortgage activity (Q4 portfolio sale ~$10M with ~$108k gain and an expected $30M sale in Q1); operating noninterest expense was $24.4M in Q4 (net noninterest expense / average assets 1.58% with a target closer to 1.45% by Q2 2026 as merger cost saves are realized after the systems conversion); provision expense was $1.65M and net charge‑offs were $1.6M (SBA/marketplace loans ≈5% of portfolio); deposits excluding the acquisition grew ~$24.3M in Q4 and were flat YoY, investments with ~$65M rolling off in 2026 at a ~3.10% yield will reprice, and capital/return metrics include TCE of 8.30%, tangible book of $14.31 (from $14.24), AOCI improvement of ~$2.5M, share repurchases of 47k at $16.50, a quarterly dividend raised to $0.12, and expected merger earn‑back of under 2.5 years.

Colony Bankcorp Financial Statement Overview

Summary
Strong multi-year revenue growth and solid profitability support the profile, and the balance sheet shows improving capital (higher equity and reported debt dropping to zero in 2025). Offsetting this, returns softened (ROE down vs. 2023–2024) and cash generation is the key risk due to sharp 2025 operating/FCF decline and historical volatility.
Income Statement
74
Positive
Revenue has grown strongly over the period (from $87.4M in 2020 to $186.1M in 2025), with 2025 showing a particularly sharp jump versus 2024. Profitability is solid for a regional bank, with net margin improving to ~15.2% in 2025 from ~13.5% in 2024. The main watch-out is margin variability versus earlier years (net margin was higher in 2021–2022), suggesting earnings power is not steadily compounding even as revenue rises.
Balance Sheet
66
Positive
The balance sheet shows improving capital position, with equity rising to ~$375.9M in 2025 from ~$278.7M in 2024, and reported debt dropping to $0 in 2025 (versus ~$248.0M in 2024). Return on equity remains acceptable but slightly lower in 2025 (~7.5%) than in 2023–2024 (~8.5%), implying profitability is not fully keeping pace with the growing equity base. Prior years also showed moderate leverage (debt-to-equity near ~0.9 in 2022–2024), so the sudden 2025 debt shift is a key item to monitor for consistency and sustainability.
Cash Flow
45
Neutral
Cash generation is the weakest area. Operating cash flow and free cash flow fell sharply in 2025 to ~$9.6M from ~$23.4M in 2024 (a steep decline year over year), despite higher net income. Cash flow has also been volatile historically, including negative operating and free cash flow in 2020. While 2025 free cash flow still roughly matches net income, the trajectory and variability reduce confidence in the durability of cash conversion.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue186.11M176.62M160.55M126.56M106.88M
Gross Profit123.56M112.40M110.28M112.33M101.78M
EBITDA35.13M37.70M35.91M34.48M31.78M
Net Income28.25M23.87M21.75M19.54M18.66M
Balance Sheet
Total Assets3.74B3.11B3.05B2.94B2.69B
Cash, Cash Equivalents and Short-Term Investments411.12M64.84M432.72M453.14M957.14M
Total Debt268.43M248.04M238.44M203.35M88.45M
Total Liabilities3.36B2.83B2.80B2.71B2.47B
Stockholders Equity375.92M278.68M254.94M230.27M217.71M
Cash Flow
Free Cash Flow-6.90M22.32M17.36M46.85M30.27M
Operating Cash Flow9.59M23.40M20.98M49.74M36.10M
Investing Cash Flow1.29M101.16M-98.75M-448.23M-208.33M
Financing Cash Flow-10.72M23.15M80.41M281.93M185.95M

Colony Bankcorp Technical Analysis

Technical Analysis Sentiment
Positive
Last Price17.00
Price Trends
50DMA
19.54
Negative
100DMA
18.28
Positive
200DMA
17.37
Positive
Market Momentum
MACD
-0.12
Positive
RSI
45.20
Neutral
STOCH
30.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CBAN, the sentiment is Positive. The current price of 17 is below the 20-day moving average (MA) of 19.79, below the 50-day MA of 19.54, and below the 200-day MA of 17.37, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 45.20 is Neutral, neither overbought nor oversold. The STOCH value of 30.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CBAN.

Colony Bankcorp Risk Analysis

Colony Bankcorp disclosed 44 risk factors in its most recent earnings report. Colony Bankcorp reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Colony Bankcorp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$308.98M8.219.62%3.57%10.93%42.68%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$388.83M13.737.79%5.43%5.76%21.85%
67
Neutral
$305.76M8.5112.70%5.24%10.46%18.70%
67
Neutral
$332.40M9.7213.35%2.63%11.98%-10.12%
62
Neutral
$410.63M10.648.98%2.55%6.92%26.93%
56
Neutral
$282.81M9.1910.77%3.17%4.43%-12.94%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CBAN
Colony Bankcorp
19.40
3.48
21.89%
CZNC
Citizens & Northern
21.71
2.22
11.40%
FNLC
First Bancorp
27.13
3.55
15.07%
PLBC
Plumas Bancorp
47.79
4.61
10.67%
FSBW
FS Bancorp
37.70
1.72
4.77%
PCB
PCB Bancorp
21.72
3.56
19.58%

Colony Bankcorp Corporate Events

Business Operations and StrategyExecutive/Board ChangesDividendsFinancial Disclosures
Colony Bankcorp Posts Strong Q4 Results, Raises Dividend
Positive
Jan 28, 2026

On January 24, 2026, Colony Bank renewed Chief Financial Officer Derek Shelnutt’s employment with a new two-year agreement that maintains him as CFO of both the holding company and the bank, sets a $300,000 annual base salary with performance-based bonus eligibility, and outlines severance protections of up to 1.5 times salary and prior-year bonus in certain termination and change-in-control scenarios, alongside non-compete and non-solicitation covenants. On January 28, 2026, the company reported stronger fourth-quarter 2025 results, with net income rising to $7.8 million and operating net income to $8.9 million, driven by higher net interest income, an expanded net interest margin, loan and deposit growth largely tied to the December 1, 2025 acquisition of TC Bancshares’ TC Federal, and higher noninterest income, while also noting increased credit loss provisions, higher noninterest expenses from integration costs and a wire-fraud loss, a larger credit loss reserve, and a solid capital position; the board raised the quarterly dividend to $0.12 per share, underscoring confidence in the bank’s capital strength and earnings trajectory for shareholders.

The most recent analyst rating on (CBAN) stock is a Buy with a $21.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.

Business Operations and StrategyStock Buyback
Colony Bankcorp Extends Common Stock Repurchase Program
Positive
Dec 22, 2025

On December 18, 2025, Colony Bankcorp’s board of directors extended the company’s existing stock repurchase program, originally approved in October 2022 and previously extended in December 2024, allowing the company to continue buying back up to $12 million of its common stock through the end of 2026. The company has repurchased 318,778 shares totaling $4.613 million since the program began, leaving $7.387 million available; the revised authorization preserves flexibility on timing, volume, and methods of repurchase, reflecting ongoing capital management priorities while allowing the company to adjust or terminate the program based on market conditions, regulatory requirements, and liquidity needs.

The most recent analyst rating on (CBAN) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 14, 2026